<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01526811</url>
  </required_header>
  <id_info>
    <org_study_id>P#8888</org_study_id>
    <nct_id>NCT01526811</nct_id>
  </id_info>
  <brief_title>Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms (ENDURANT France)</brief_title>
  <official_title>Post-market Study on Endurant™ Stent Graft System in the Treatment of Infra-renal Abdominal Aortic Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Endovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Endovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the benefits of endovascular repair with Endurant
      Stent Graft System by documenting overall mortality, complications, the rate of conversion to
      open surgical repair, and the development and rupture of the aneurysm on a long term, i.e. at
      5 years, in a cohort of patients representative of the population treated under real-life
      conditions of use in France.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Data regarding the use under routine practice of abdominal aortic stent grafts in France are
      expected by the French National Authority for Health (HAS). Therefore, in its opinion report
      from July 13, 2010, HAS makes the maintenance of reimbursement approval of each stent graft
      dependent on the presentation of results of a specific follow-up study carried out in a
      cohort of patients representative of the French population treated under real-life conditions
      of use. This prospective cohort study must involve at least 150 patients implanted after
      registration on the LPPR (List of Products and Services qualifying for Reimbursement). The
      results of the follow-up study must be forwarded to the National Committee for Evaluation of
      Medical Devices and Health Technologies (CNEDiMTS) for examination once a year. The
      assessment of this follow-up could lead to the recommendation by CNEDiMTS to continue or stop
      the reimbursement of the concerned stent graft.

      In France, The Endurant™ Stent Graft System is registered on the LPPR for a period of 3 years
      since September 13, 2011. In order to comply with HAS expectations, Medtronic Bakken Research
      Center is setting up this long term non-interventional study on the Endurant stent graft.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Aneurysm diameter's change</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent graft endoleaks (type I, II and III)</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stent Graft migration</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Conversion to open surgical repair</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgical or endovascular secondary procedures</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Aneurysm-related mortality</measure>
    <time_frame>through 5 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">180</enrollment>
  <condition>Aneurysm</condition>
  <condition>Aortic Aneurysm</condition>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <condition>Vascular Diseases</condition>
  <condition>Cardiovascular Diseases</condition>
  <condition>Aortic Diseases</condition>
  <arm_group>
    <arm_group_label>AAA patients</arm_group_label>
    <description>Subjects presenting with a non-ruptured infra-renal abdominal aortic aneurysm (AAA) and requiring endovascular treatment with Endurant™ Stent Graft, and who meet the inclusion/exclusion criteria are intended to participate in this non-interventional study</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endurant Stent graft</intervention_name>
    <description>Endurant Stent graft implantation</description>
    <arm_group_label>AAA patients</arm_group_label>
    <other_name>EVAR</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects diagnosed with a non-ruptured infra-renal abdominal aortic aneurysm (AAA) and
        requiring endovascular treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient with age ≥18 years, who is able to understand the information given by the
             investigator regarding the collection and release of his/her personal information and
             who is able to oppose to this collection and release.

          -  Any patient requiring placement of an abdominal aortic stent graft for the treatment
             of a non-ruptured infra-renal abdominal aortic aneurysm.

          -  Patient not opposed to the collection and release of his/her personal information

          -  Intention of physician to implant electively the Endurant™ Stent Graft System

        Exclusion Criteria:

          -  Patient in whom clinical follow-up will not be possible i.e. patient not able to come
             back for follow-up visits (ex. patient living abroad)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Pierre Becquemin, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupe Hospitalier Henri-Mondor, Créteil, France</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier d'Avignon</name>
      <address>
        <city>Avignon</city>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Besancon, Hôpital Jean Minjoz</name>
      <address>
        <city>Besançon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médipôle de Savoie</name>
      <address>
        <city>Challes-les-Eaux</city>
        <zip>73190</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Sainte Marie</name>
      <address>
        <city>Chalon sur Saône</city>
        <zip>71100</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Henri-Mondor</name>
      <address>
        <city>Créteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Claude Bernard</name>
      <address>
        <city>Ermont</city>
        <zip>95120</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Mousseau</name>
      <address>
        <city>Evry</city>
        <zip>91035</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique de la Présentation</name>
      <address>
        <city>Fleury les Aubrais</city>
        <zip>45404</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87042</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé Jean Mermoz</name>
      <address>
        <city>Lyon</city>
        <zip>69008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Paul Desbief</name>
      <address>
        <city>Marseille</city>
        <zip>13002</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Ambroise Paré</name>
      <address>
        <city>Marseille</city>
        <zip>13006</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint Joseph</name>
      <address>
        <city>Marseille</city>
        <zip>13008</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique du Millenaire</name>
      <address>
        <city>Montpellier</city>
        <zip>34960</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Polyclinique Quimper Sud</name>
      <address>
        <city>Quimper</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Belledonne</name>
      <address>
        <city>Saint-Martin-d'Hères</city>
        <zip>38400</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHl Toulon - La Seyne sur Mer</name>
      <address>
        <city>Toulon</city>
        <zip>83056</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Sarrus Teinturiers</name>
      <address>
        <city>Toulouse</city>
        <zip>31300</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinique Saint Joseph</name>
      <address>
        <city>Trélazé</city>
        <zip>49800</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2012</study_first_submitted>
  <study_first_submitted_qc>February 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 6, 2012</study_first_posted>
  <last_update_submitted>January 4, 2018</last_update_submitted>
  <last_update_submitted_qc>January 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Endurant</keyword>
  <keyword>Stent Graft</keyword>
  <keyword>Abdominal Aortic Aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
    <mesh_term>Aortic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

